Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients

Objective: To investigate characteristics of multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) patients associated with drugs other than natalizumab since our experience in other disease-modifying drugs (DMD) is still limited. Methods: This is a descriptive observational study within t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis 2019-07, Vol.25 (8), p.1141-1149
Hauptverfasser:	Oshima, Yasuo, Tanimoto, Tetsuya, Yuji, Koichiro, Tojo, Arinobu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Cohort Studies Encephalitis Female Fingolimod Hydrochloride - adverse effects Humans Immunologic Factors - adverse effects Immunotherapy Leukoencephalopathy Leukoencephalopathy, Progressive Multifocal - chemically induced Male Middle Aged Monoclonal antibodies Multiple sclerosis Multiple Sclerosis - drug therapy Natalizumab - adverse effects Progressive multifocal leukoencephalopathy Rituximab Rituximab - adverse effects Viral infections
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!